Textiles treated with the technology have also been proven to deactivate viruses, including SARS-CoV-2 (the virus that causes COVID-19).
First diagnostic centre to open in Mohali on August 31
The company has to approach the DCGI for approval to commence the trials
In H1FY21, it attracted PE deals worth US $ 1.6 billion compared to US $ 3 billion in CY2020
New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
Employees of QubeHealth’s corporate clients draw as much money as they need to instantly pay for any medical emergencies or regular healthcare payments
The company expects a potential sales turnover of Rs.350-500 crores at 100 % capacity utilization
This multi-centre study (sites in the US and Europe) comprising about 387 patients is likely to be completed in about 36 months and the topline result is expected by the end of 2024
EPS for the period at Rs. (7.57)
Subscribe To Our Newsletter & Stay Updated
